Início › Tumores Cerebrais › Texas
Ensaios clínicos de Tumores Cerebrais em Texas
42 estudos para Tumores Cerebrais estão buscando participantes em locais em Texas.
Cidades em Texas
Texto oficial do estudo (Inglês)
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
- Baylor St. Luke's Medical Center, Houston
RecrutandoFase 1
Idades de 21 a 70 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06815432Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Baylor, Scott and White Research Institute, Dallas
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
- Mays Cancer Center, UT Health San Antonio, San Antonio
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07470606Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
- The University of Texas M. D. Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07053033A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT05048212A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0085, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07492680Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- MD Anderson Cancer Center, Houston
- START San Antonio, San Antonio
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT05786924Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
RecrutandoFase 2
59 Months · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT05535166OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07655583Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT04988009A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NEXT Oncology - Austin, Austin
- Mary Crowley Cancer Research, Dallas
- MD Anderson Cancer Center - University of Texas, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT05386108A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
- MD Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07467109A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- UT MD Anderson Cancer Center, Houston
- UT Health San Antonio Mays Cancer Center, San Antonio
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07428616Targeted Pediatric High-Grade Glioma Therapy
- Texas Children's Hospital, Houston
RecrutandoEstudo observacional
12 Months – 39 Years · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
36 Months – 22 Years · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT03911388Study of Olutasidenib and Temozolomide in HGG
- Texas Children's Hospital, Houston
RecrutandoFase 2
Idades de 12 a 39 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06161974A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
- MD Anderson Cancer Center, Houston
- Community Clinical Trials, Kingwood
- Tranquil Clinical Research, Webster
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06764940A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
- Mary Crowley Cancer Research, Dallas
- The University of Texas M.D. Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06136884Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
- Ut Southwestern Medical Center, Dallas
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT07139990Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
- Houston Methodist Neal Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT07383649Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
- Excel Diagnostics & Nuclear Oncology Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT07733674C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
- Texas Children's Hospital, Houston
RecrutandoFase 1
12 Months – 25 Years · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT04099797Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- UT Southwestern Simmons Cancer Center, Dallas
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
- e mais 2
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT04427384A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT05673928Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- M D Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 19 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT03830151Mapping of Human Cognition
- The University of Texas Health Science Center at Houston, Houston
Recrutando
Idades de 18 a 75 · Todos os sexos · Atualizado em 14 de jul. de 2026 · NCT05989893Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Texas Children's Hospital, Houston
RecrutandoFase 2
12 Months – 39 Years · Todos os sexos · Atualizado em 29 de mai. de 2026 · NCT05843253Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
- M D Anderson Cancer Center, Houston
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 20 de mai. de 2026 · NCT02754544A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 20 de mai. de 2026 · NCT05342454Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de abr. de 2026 · NCT05064280EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
- The University of Texas MD Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de abr. de 2026 · NCT06649058Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- MD Anderson Cancer Center, Houston
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT06810544The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Md Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mar. de 2026 · NCT04075305Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
- M D Anderson Cancer Center, Houston
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de fev. de 2026 · NCT05700721cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Elligo Health Research, Inc., Austin
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 40 e acima · Todos os sexos · Atualizado em 20 de jan. de 2026 · NCT05366881Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
- MD Anderson Cancer Center, Houston
Recrutando
Idades de 15 a 39 · Todos os sexos · Atualizado em 9 de jan. de 2026 · NCT06799481S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- UT Southwestern Clinical Center at Richardson/Plano, Richardson
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de out. de 2025 · NCT03418961Systematic Light Exposure in Pediatric Brain Tumor Survivors
- Texas Children's Hospital, Houston
Recrutando
Idades de 10 a 18 · Todos os sexos · Atualizado em 18 de set. de 2025 · NCT05340881A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- MD Anderson, Houston
- NEXT Oncology, San Antonio
RecrutandoFase 1/2
Idades de 18 a 89 · Todos os sexos · Atualizado em 19 de ago. de 2025 · NCT06907043Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.